What the New Research on Ozempic and Aging Really Means

The most talked-about medicines of the decade may have found a second act. GLP-1 drugs such as Ozempic and Wegovy already change the number on the scale, and new data suggests they may also slow the body's internal clock.

As CNN reported in a story carried by CTV News on October 14, Novo Nordisk and Eli Lilly both say patients on their drugs showed slower biological aging than people who did not take them. The research on Ozempic and aging is early and comes from the companies that sell the drugs, which makes it a promising signal rather than a reason to start a prescription.

Key takeaways

Novo Nordisk reported that semaglutide, the drug in Ozempic and Wegovy, slowed biological aging by about two to three years on most aging clocks, compared with placebo.

One clock built from heart-related proteins showed a slowdown of roughly four years.

Eli Lilly reported a smaller analysis pointing the same way for tirzepatide, sold as Mounjaro.

Researchers do not yet know whether the effect comes from weight loss or from the drugs themselves.

No regulator, including Health Canada, has approved a GLP-1 drug to slow aging.

What did the aging clocks actually show?

Aging clocks are tests that estimate how old your body is at a molecular level by reading changes in DNA or levels of key proteins in the blood. Your biological age and your calendar age can differ, and researchers treat the gap as a measure of how well the body is holding up.

According to MIT Technology Review's report from the Aging Research and Drug Discovery conference, Novo Nordisk analyzed blood samples from more than 10,000 people in earlier semaglutide trials. Most clocks showed a slowdown of about two to three years compared with placebo, and one clock built from heart proteins showed roughly four. Eli Lilly shared a smaller analysis of tirzepatide users over 50 that pointed the same way.

Is it the drug or the weight loss doing the work?

The biggest open question is whether the slower clocks come from the drugs themselves or from weight loss. Cutting calories extends lifespan in many animals, and the CNN report notes it is still unclear whether GLP-1 drugs act on aging independently of the weight they take off.

A separate study in mice, co-led by researchers at the University of California, Berkeley, and published in Nature, found that GLP-1 treatment extended lifespan, as did cutting calories, with some differences between the two groups. Danica Chen, a Berkeley professor who studies calorie restriction and aging, has pointed out that age is the biggest risk factor for many illnesses. A treatment aimed at aging itself could, in theory, help with many of them at once.

Should anyone take semaglutide to live longer?

Experts quoted in the coverage say it is too early for anyone to take semaglutide or any other GLP-1 drug purely in the hope of living longer. The studies so far involved people with overweight or type 2 diabetes, and it is still unknown whether people at a healthy weight would see any benefit.

These are prescription medicines with real side effects, including nausea and the loss of some muscle along with fat, and no regulator anywhere, including Health Canada, has approved them to slow aging. A federally funded study in Texas plans to test semaglutide in healthy adults over 60, with results possible in a year or two.

Why does it matter that drugmakers ran these studies?

The data comes from the drugmakers that sell these medicines, and the companies presented it at a scientific conference. That does not make the findings wrong, and independent aging scientists are genuinely interested, yet it is the kind of detail a careful reader keeps in mind while the results await longer trials and outside scrutiny.

Aging clocks themselves are also new tools, and different clocks gave quite different answers in these analyses. A slower clock reading is a promising sign, though it is still unproven that it translates into a longer or healthier life.

The findings are promising, early, and unproven, and no GLP-1 drug is approved to slow aging.

What if you already take a GLP-1 medication?

For the many Canadians already taking a GLP-1 medication for diabetes or weight management, the takeaway is gentler. The medicine you take for one reason may be doing more for your long-term health than its label suggests, and future research will sharpen that picture. If you are on one, our guide to whether you are eating enough protein matters more than usual, since protecting muscle is part of losing weight well.

Keep your current plan. These findings are too early to act on, so keep following the plan you made with your prescriber.

Bring it up at your next visit. Aging research is a fair question, and your doctor can put it in the context of your own health.

Protect your muscle. Eat enough protein and include strength training, especially while you are losing weight.

Stay active. Movement shapes how you age with or without medication, and it helps you keep muscle while the scale drops.

Get advice before starting one. Whether a GLP-1 medication suits you depends on your weight, blood sugar, health history, and goals.

Staying active deserves its own mention, since a study found that people on Ozempic and other GLP-1 drugs are moving less. If you are curious about these drugs in general, our explainer on how weight loss drugs work is a good primer before you talk to a professional.

Frequently asked questions

Does Ozempic slow aging?

Early data from Novo Nordisk suggests semaglutide, the drug in Ozempic and Wegovy, slowed biological aging by about two to three years on most aging clocks compared with placebo. The research on Ozempic and aging is preliminary, comes from the drugmaker, and involves people with overweight or diabetes, so it does not show that the drug extends life.

Can I take a GLP-1 drug to live longer?

Experts say it is too early to take a GLP-1 drug purely to live longer. The studies involved people with overweight or type 2 diabetes, and it is unknown whether healthy-weight people would benefit. These are prescription medicines with real side effects, and no regulator, including Health Canada, has approved them for aging.

What is an aging clock?

An aging clock is a test that estimates your biological age from molecular markers in the blood, such as chemical changes to DNA or levels of certain proteins. Biological age can run ahead of or behind your calendar age. Researchers use these clocks to study aging, though they are still new and different clocks can disagree.

Does losing weight slow aging too?

Cutting calories extends lifespan in many animals, and weight loss itself may explain part of the effect seen with GLP-1 drugs. Researchers do not yet know how much of the slowdown comes from weight loss and how much from the drugs. Healthy eating, regular activity, and good sleep all support healthy aging in any case.

Your next step

A doctor can walk you through whether a GLP-1 medication fits your situation, and whether the news on Ozempic and aging changes anything for you. The Medimap Health Hub has more on weight, nutrition, and everyday habits, and you can book with a family practice near you on Medimap to start that conversation.

Disclaimer: This article is for general information only and is not medical advice. It does not replace a conversation with a doctor or other qualified health professional who knows your history. If you think you are having a medical emergency, call 911 or go to the nearest emergency department.